Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 19

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The enhanced antibacterial and antibiofilm properties of titanium dioxide nanoparticles biosynthesized by multidrug-resistant Pseudomonas aeruginosa

Haji, Sayran Hamad, Ganjo, Aryan R., Faraj, Tola A., Fatah, Mohammed H., Smail, Sakar B. · 2024 · BMC Microbiology

Abstract

The emergence of Multidrug-resistant (MDR) bacteria are becoming a major worldwide health concern, encouraging the development effective alternatives to conventional antibiotics. The study identified P. aeruginosa and assessed its antimicrobial sensitivity using the Vitek-2 system. Carbapenem-resistant genes were detected through Polymerase chain reaction (PCR). MDR- P. aeruginosa isolates were used to biosynthesize titanium dioxide nanoparticles (TiO 2 NPs) and characterized using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM). A study involving 78 P. aeruginosa isolates revealed that 85.8% were MDR, with meropenem and amikacin showing effectiveness against 70% of the isolates. The most prevalent carbapenemase gene was bla OXA-48 , present in 83% of the isolates. Majority of the isolates formed biofilms, and biosynthesized TiO 2 NPs were able to reduce biofilm formation by 94%. TiO 2 NPs exhibited potent antibacterial action against MDR-Gram-negative bacilli pathogens and showed synergistic activity with antibiotics, particularly piperacillin, with a significant fold increase in areas (283%). A new local strain of P. aeruginosa , identified as ON678251 in the World GenBank, was found capable of producing TiO 2 NPs. Our findings demonstrate the potential of biosynthesized TiO 2 NPs to manage antibiotic resistance and regulate the formation of biofilms. This presents a promising direction for the creation of novel antimicrobial agents or substitutes for use in clinical settings, particularly in the management of isolates capable of resisting multiple drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12866-024-03530-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 67

  1. Shaaban M, Al-Qahtani A, Al-Ahdal M, Barwa R. Molecular characterization of resistance mechanisms in Pseudomonas aeruginosa isolates resistant to carbapenems. J Infect Dev Ctries. 2017;11(12):935–43. · doi:10.3855/jidc.9501
  2. de Sousa T, Hébraud M, Alves O, Costa E, Maltez L, Pereira JE, Martins Â, Igrejas G, Poeta P. Study of antimicrobial resistance, biofilm formation, and motility of Pseudomonas aeruginosa derived from urine samples. Microorganisms. 2023;11(5):1345. · DOI
  3. Gajdács M, Baráth Z, Kárpáti K, Szabó D, Usai D, Zanetti S, Donadu MG. No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics. 2021;10(9):1134. · DOI
  4. van Burgh S, Maghdid DM, Ganjo AR, Mansoor IY, Kok DJ, Fatah MH, Alnakshabandi AA, Asad D, Hammerum AM, Ng K. PME and other ESBL-positive multiresistant Pseudomonas aeruginosa isolated from hospitalized patients in the region of Kurdistan, Iraq. Microb Drug Resist. 2019;25(1):32–8. · DOI
  5. Rezaei H, Iranbakhsh A, Sepahi AA, Mirzaie A, Larijani K. Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities. Sci Rep. 2024;14(1):16692. · doi:10.1038/s41598-024-67509-5
  6. Ratajczak M, Kamińska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinical strains. Ann Agric Environ Med. 2021;28(2):306–13. · doi:10.26444/aaem/122682
  7. Ramadan RA, Gebriel MG, Kadry HM, Mosallem A. Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations. Infect Drug Resist. 2018;11:1261–9. · DOI
  8. Ahmed FY, Aly UF, Abd El-Baky RM, Waly N. Effect of Titanium Dioxide Nanoparticles on the Expression of Efflux Pump and Quorum-Sensing Genes in MDR Pseudomonas aeruginosa Isolates. Antibiotics (Basel, Switzerland). 2021;10(6):1–15.
  9. Składanowski M, Wypij M, Laskowski D, Golińska P, Dahm H, Rai M. Silver and gold nanoparticles synthesized from Streptomyces sp. isolated from acid forest soil with special reference to its antibacterial activity against pathogens. J Cluster Sci. 2017;28(1):59–79. · DOI · Paper page
  10. Parvathy S, Manjula G, Balachandar R, Subbaiya R. Green synthesis and characterization of cerium oxide nanoparticles from Artabotrys hexapetalus leaf extract and its antibacterial and anticancer properties. Mater Lett. 2022;314:131811. · doi:10.1016/j.matlet.2022.131811
  11. Huq M, Akter S. Biosynthesis, characterization and antibacterial application of novel silver nanoparticles against drug resistant pathogenic Klebsiella pneumoniae and Salmonella Enteritidis. Molecules. 2021;26(19):5996. · DOI
  12. Ahmed FY, Aly UF, Abd El-Baky RM, Waly NG. Effect of titanium dioxide nanoparticles on the expression of efflux pump and quorum-sensing genes in MDR Pseudomonas aeruginosa isolates. Antibiotics. 2021;10(6):625. · doi:10.3390/antibiotics10060625
  13. Palaskar RS, Dhokane DS, Ankamwar BG. Green-Synthesized Nanoparticles to Combat Multidrug-Resistant Bacteria. In: Wani MY, Wani IA, Rai A. eds. Nanotechnology Based Strategies for Combating Antimicrobial Resistance. Singapore: Springer; 2024. https://doi.org/10.1007/978-981-97-2023-1_19. · DOI
  14. Ssekatawa K, Byarugaba DK, Kato CD, Ejobi F, Tweyongyere R, Lubwama M, Kirabira JB, Wampande EM. Nanotechnological solutions for controlling transmission and emergence of antimicrobial-resistant bacteria, future prospects, and challenges: a systematic review. J Nanopart Res. 2020;22(5):1–30. · DOI
  15. Rai M, Ingle AP, Pandit R, Paralikar P, Gupta I, Chaud MV, Dos Santos CA. Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance. Int J Pharm. 2017;532(1):139–48. · DOI
  16. Bassetti M, Vena A, Sepulcri C, Giacobbe DR, Peghin M. Treatment of bloodstream infections due to Gram-negative bacteria with difficult-to-treat resistance. Antibiotics. 2020;9(9):632. · DOI
  17. San Diego KD, Alindayu JIA, Baculi RQ. Biosynthesis of gold nanoparticles by bacteria from hyperalkaline spring and evaluation of their inhibitory activity against pyocyanin production. J Microbiol Biotechnol Food Sci. 2021;2021:781–7.
  18. Arul Selvaraj RC, Rajendran M, Nagaiah HP. Re-potentiation of β-lactam antibiotic by synergistic combination with biogenic copper oxide nanocubes against biofilm forming multidrug-resistant bacteria. Molecules. 2019;24(17):3055. · DOI
  19. Al Sanjee S, Hassan MM, Manchur M. In vitro biofilm formation by multidrug resistant clinical isolates of Pseudomonas aeruginosa. Asian J Med Biol Res. 2018;4(1):105–16. · doi:10.3329/ajmbr.v4i1.36828
  20. Hassan H, Omoniyi K, Okibe F, Nuhu A, Echioba E. Assessment of wound healing activity of green synthesized titanium oxide nanoparticles using strychnos spinosa and blighia sapida. J Appl Sci Environ Manag. 2020;24(2):197–206.
  21. Khan R, Fulekar M. Biosynthesis of titanium dioxide nanoparticles using Bacillus amyloliquefaciens culture and enhancement of its photocatalytic activity for the degradation of a sulfonated textile dye Reactive Red 31. J Colloid Interface Sci. 2016;475:184–91. · doi:10.1016/j.jcis.2016.05.001
  22. Peiris M, Fernando S, Jayaweera P, Arachchi N, Guansekara T. Comparison of antimicrobial properties of silver nanoparticles synthesized from selected bacteria. Indian J Microbiol. 2018;58(3):301–11. · DOI
  23. Kirthi AV, Rahuman AA, Rajakumar G, Marimuthu S, Santhoshkumar T, Jayaseelan C, Elango G, Zahir AA, Kamaraj C, Bagavan A. Biosynthesis of titanium dioxide nanoparticles using bacterium Bacillus subtilis. Mater Lett. 2011;65(17–18):2745–7. · DOI · Paper page
  24. Khaksarian M, Bahmani M, Taherikalani M, Ashrafi B, Rafieian-Kopaei M, Abbasi N. Biosynthesis of titanium dioxide nanoparticles using hypericum perforatum and origanum vulgare extracts and their main components, hypericin and carvacrol as promising antibacterial agents. J Tradit Chin Med. 2022;42(2):167.
  25. Landage K, Arabade G, Khanna P, Bhongale C. Biological approach to synthesize TiO2 nanoparticles using Staphylococcus aureus for antibacterial and anti-biofilm applications. J Microbiol Exp. 2020;8(1):36–43.
  26. Khaksarian M, Bahmani M, Taherikalani M, Ashrafi B, Rafieian-Kopaei M, Abbasi N. Biosynthesis of titanium dioxide nanoparticles using Hypericum perforatum and Origanum vulgare extracts and their main components, hypericin and carvacrol as promising antibacterial agents. J Tradit Chin Med 2022.42(2):167–75. https://pubmed.ncbi.nlm.nih.gov/35473336/.
  27. Abdel-Wahab F, El Menofy N, El-Batal A, Mosallam F, Abdulall A. Enhanced antimicrobial activity of the combination of silver nanoparticles and different β Lactam antibiotics against methicillin resistant Staphylococcus aureus isolates. Azhar Int J Pharm Med Sci. 2021;1(1):22–31.
  28. Altaai ME, Aziz IH, Marhoon AA. Identification Pseudomonas aeruginosa by 16s rRNA gene for differentiation from other Pseudomonas species that isolated from patients and environment. Baghdad Sci J. 2014;11(2):1028–34. · doi:10.21123/bsj.2014.11.2.1028-1034
  29. Subramaniyan JS, Sundaram JM. Occurrence of bla genes encoding carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from intensive care unit in a tertiary care hospital. J Lab Physicians. 2018;10(02):208–13. · doi:10.4103/jlp.jlp_108_17
  30. Ganjo AR, Ali FA, Aka ST, Hussen BM, Smail SB. Diversity of biofilm-specific antimicrobial resistance genes in Pseudomonas aeruginosa recovered from various clinical isolates. Iran J Microbiol. 2023;15(6):742.
  31. Jin C, Zhou F, Cui Q, Qiang J, An C. Molecular characteristics of carbapenem-resistant enterobacter cloacae in a tertiary Hospital in China. Infection and drug resistance 2020;13:1575–81. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266308/. · doi:10.2147/idr.s254056
  32. Sedighi M, Vaez H, Moghoofeie M, Hadifar S, Oryan G, Faghri J. Molecular detection of metallo-β-lactamase gene blaVIM-1 in imipenem-resistant Pseudomonas aeruginosa strains isolated from hospitalized patients in the hospitals of Isfahan. Adv Biomed Res. 2015;4(1):57. · doi:10.4103/2277-9175.151872
  33. Sheikh AF, Shahin M, Shokoohizadeh L, Ghanbari F, Solgi H, Shahcheraghi F. Emerge of NDM-1-producing multidrug-resistant Pseudomonas aeruginosa and co-harboring of carbapenemase genes in South of Iran. Iran J Public Health. 2020;49(5):959.
  34. Ratajczak M, Kaminska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibioticresistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinicalstrains. Ann Agric Environ Med. 2021;28(2):306–13. · doi:10.26444/aaem/122682
  35. Farajzadeh Sheikh A, Shahin M, Shokoohizadeh L, Ghanbari F, Solgi H, Shahcheraghi F. Emerge of NDM-1-producing multidrug-resistant Pseudomonas aeruginosa and Co-Harboring of Carbapenemase genes in South of Iran. Iran J Public Health. 2020;49(5):959–67.
  36. Rahimi E, Asgari A, Azimi T, Soleiman-Meigooni S. Molecular detection of carbapenemases and extended-spectrum β-lactamases-encoding genes in clinical isolates of Pseudomonas aeruginosa in Iran. Jundishapur J Microbiol. 2021;14(7). · doi:10.5812/jjm.115977
  37. Leão AC, Menezes PR, Oliveira MS, Levin AS. Acinetobacter spp are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. BMC Infect Dis. 2016;16:386. · doi:10.1186/s12879-016-1695-8
  38. Sadeghi MR, Ghotaslou R, Akhi MT, Asgharzadeh M, Hasani A. Molecular characterization of extended-spectrum β-lactamase, plasmid-mediated AmpC cephalosporinase and carbapenemase genes among Enterobacteriaceae isolates in five medical centres of East and West Azerbaijan. Iran J Med Microbiol. 2016;65(11):1322–31. · doi:10.1099/jmm.0.000356
  39. Nastro M. Carbapenemen-resistant Enterobacterales: an issue of global concern. Rev Argent Microbiol. 2024;56(2):113–4.
  40. Nieto-Rosado M, Sands K, Portal EA, Thomson KM, Carvalho MJ, Mathias J, Milton R, Dyer C, Akpulu C, Boostrom I. Colonisation of hospital surfaces from low-and middle-income countries by extended spectrum β-lactamase-and carbapenemase-producing bacteria. Nat Commun. 2024;15(1):2758. · DOI
  41. El-Badawy MF, El-Far SW, Althobaiti SS, Abou-Elazm FI, Shohayeb MM. The First Egyptian Report Showing the Co-Existence of bla (NDM-25), bla (OXA-23), bla (OXA-181), and bla (GES-1) Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR. Infect Drug Resist. 2020;13:1237–50. · doi:10.2147/idr.s244064
  42. Mahrach Y, Mourabit N, Arakrak A, Bakkali M, Laglaoui A. Phenotypic and molecular study of carbapenemase-producing Enterobacteriaceae in a regional hospital in northern Morocco. J Clin Med Sci. 2019;3:113.
  43. Younis AB, Milosavljevic V, Fialova T, Smerkova K, Michalkova H, Svec P, Antal P, Kopel P, Adam V, Zurek L. Synthesis and characterization of TiO2 nanoparticles combined with geraniol and their synergistic antibacterial activity. BMC Microbiol. 2023;23(1):207. · DOI
  44. Rathore C, Yadav VK, Gacem A, AbdelRahim SK, Verma RK, Chundawat RS, Gnanamoorthy G, Yadav KK, Choudhary N, Sahoo DK. Microbial synthesis of titanium dioxide nanoparticles and their importance in wastewater treatment and antimicrobial activities: a review. Front Microbiol. 2023;14:1270245. · doi:10.3389/fmicb.2023.1270245
  45. Babaei H, Sepahy AA, Amini K, Saadatmand S. The effect of titanium dioxide nanoparticles synthesized by Bacillus tequilensis on clb gene expression of colorectal cancer-causing Escherichia coli. Arch Pharm Pract. 2020;11(1):22–31.
  46. Tharanya P, Vadakkan K, Hemapriya J, Kannan V, Vijayanand S. Biogenic approach for the synthesis of titanium dioxide nanoparticles using a halophilic bacterial isolate-Chromohalobacter salexigens strain PMT-1. Int J Curr Res Acad Rev. 2015;3:334–42.
  47. Órdenes-Aenishanslins NA, Saona LA, Durán-Toro VM, Monrás JP, Bravo DM, Pérez-Donoso JM. Use of titanium dioxide nanoparticles biosynthesized by Bacillus mycoides in quantum dot sensitized solar cells. Microb Cell Fact. 2014;13(1):1–10. · DOI · Paper page
  48. Hassan H, Omoniyi K, Okibe F, Nuhu A, Echioba E. Evaluation of antibacterial potential of biosynthesized plant leave extract mediated titanium oxide nanoparticles using Hypheae Thiebeace and Anannos Seneglensis. J Appl Sci Environ Manag. 2019;23(10):1795–804.
  49. Eisa NE, Almansour S, Alnaim IA, Ali AM, Algrafy E, Ortashi KM, Awad MA, Virk P, Hendi AA, Eissa FZ. Eco-synthesis and characterization of titanium nanoparticles: testing its cytotoxicity and antibacterial effects. Green Process Synth. 2020;9(1):462–8. · doi:10.1515/gps-2020-0045
  50. Ahmed FY, Farghaly Aly U, Abd El-Baky RM, Waly N. Comparative study of antibacterial effects of titanium dioxide nanoparticles alone and in combination with antibiotics on MDR Pseudomonas aeruginosa strains. Int J Nanomed. 2020;15:3393–404. · doi:10.2147/ijn.s246310
  51. Mathesh A, Mohanprasanth A, Saravanan M. Synthesis and characterization of Spirulina-mediated titanium dioxide nanoparticles: Antimicrobial activity against multidrug-resistant bacteria. Nano-Structures & Nano-Objects. 2024;39:101225. · DOI
  52. Sathiyaseelan A, Saravanakumar K, Naveen KV, Han K-S, Zhang X, Jeong MS, Wang M-H. Combination of Paraconiothyrium brasiliense fabricated titanium dioxide nanoparticle and antibiotics enhanced antibacterial and antibiofilm properties: a toxicity evaluation. Environ Res. 2022;212:113237. · DOI
  53. Annadurai G, Rajeshkumar S: Novel eco-friendly synthesis of titanium oxide nanoparticles by using Planomicrobium sp. and its antimicrobial evaluation. Der Pharmacia Sinica 2013.4(3):59–66. https://www.researchgate.net/publication/237048624_Novel_eco-friendly_synthesis_of_titanium_oxide_nanoparticles_by_using_Planomicrobium_sp_and_its_antimicrobial_evaluation.
  54. Abdulazeem L. AL-Amiedi BH, Alrubaei HA, AL-Mawlah YH: Titanium dioxide nanoparticles as antibacterial agents against some pathogenic bacteria. Drug Inven Today. 2019;12(5):963–7.
  55. Ahmed DM, Yaaqoob LA, kamaluideen Arif S. Biosynthesis of TiO2 nanoparticles using prodigiosin and evaluating its antibacterial activity against biofilm producing MDR-acinetobacter baumannii. Public Health. 2020;13:14.
  56. Abdulazeem L, Al-Amiedi B, Alrubaei HA. AL-Mawlah YH: Titanium dioxide nanoparticles as antibacterial agents against some pathogenic bacteria. Drug Invention Today. 2019;12(5):963–7.
  57. Alidoust FA, Rasti B, Zamani H, Mirpour M, Mirzaie A. Rutin-coated zinc oxide nanoparticles: a promising antivirulence formulation against pathogenic bacteria. World J Microbiol Biotechnol. 2024;40(6):184. · DOI
  58. Abbasi M, Gholizadeh R, Kasaee SR, Vaez A, Chelliapan S, Fadhil Al-Qaim F, Deyab IF, Shafiee M, Zareshahrabadi Z, Amani AM. An intriguing approach toward antibacterial activity of green synthesized Rutin-templated mesoporous silica nanoparticles decorated with nanosilver. Sci Rep. 2023;13(1):5987. · DOI
  59. Fariq A, Khan T, Yasmin A. Microbial synthesis of nanoparticles and their potential applications in biomedicine. J Appl Biomed. 2017;15(4):241–8. · DOI · Paper page
  60. Arora B, Murar M, Dhumale V. Antimicrobial potential of TiO2 nanoparticles against MDR Pseudomonas aeruginosa. J Exp Nanosci. 2015;10(11):819–27. · DOI · Paper page
  61. Roy AS, Parveen A, Koppalkar AR, Prasad MA. Effect of nano-titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus. J Biomater Nanobiotechnology. 2010;1(1):37. · doi:10.4236/jbnb.2010.11005
  62. Asadipour E, Asgari M, Mousavi P, Piri-Gharaghie T, Ghajari G, Mirzaie A. Nano-biotechnology and challenges of drug delivery system in cancer treatment pathway. Chem Biodivers. 2023;20(6):e202201072. · DOI
  63. Haji SH, Ali FA, Aka STH. Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilli. Sci Rep. 2022;12(1):15254. · DOI
  64. Zafer MM, Mohamed GA, Ibrahim SR, Ghosh S, Bornman C, Elfaky MA. Biofilm-mediated infections by multidrug-resistant microbes: a comprehensive exploration and forward perspectives. Arch Microbiol. 2024;206(3):101. · DOI
  65. Afrasiabi S, Partoazar A. Targeting bacterial biofilm-related genes with nanoparticle-based strategies. Front Microbiol. 2024;15:1387114. · DOI · Paper page
  66. Alavi M, Karimi N. Antiplanktonic, antibiofilm, antiswarming motility and antiquorum sensing activities of green synthesized Ag-TiO(2), TiO(2)-Ag, Ag-Cu and Cu-Ag nanocomposites against multi-drug-resistant bacteria. Artificial cells, nanomedicine, and biotechnology. 2018;46(sup3):S399-s413. · DOI
  67. Haddadian A, Robattorki FF, Dibah H, Soheili A, Ghanbarzadeh E, Sartipnia N, Hajrasouliha S, Pasban K, Andalibi R, Ch MH. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. Sci Rep. 2022;12(1):21938. · doi:10.1038/s41598-022-26400-x

Cited by

See all 19

Metadata

Authors
Haji, S. H., Ganjo, A. R., Faraj, T. A., Fatah, M. H., & Smail, S. B.
Venue
BMC Microbiology
Published
2024-10-01
Volume
24
Issue
1
ISSN
1471-2180
Cited by
19
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The enhanced antibacterial and antibiofilm properties of titanium dioxide nanoparticles biosynthesized by multidrug-resistant Pseudomonas aeruginosa. https://app.cochat.ai/papers/10.1186/s12866-024-03530-y
The paper
Haji, S. H., Ganjo, A. R., Faraj, T. A., Fatah, M. H., & Smail, S. B. (2024). The enhanced antibacterial and antibiofilm properties of titanium dioxide nanoparticles biosynthesized by multidrug-resistant Pseudomonas aeruginosa. BMC Microbiology. https://doi.org/10.1186/s12866-024-03530-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.